IMAGE GALLERY:
Advancing In Silico Medicine: Strengthening Dialogue with EU Policymakers
25/02/2025
BACK
On February 17, our President & Secretary General Thierry Marchal, alongside Nayara Maldonado Solís from RPP, had the opportunity to meet with the team of MEP Kulja, MD, to discuss the creation of an MEP In Silico Coalition. This initiative would establish a regular dialogue between in silico experts from the Avicenna Alliance and the VPH Institute, and MEPs committed to new technologies in healthcare.
It was encouraging to see that in silico medicine, computational modelling & simulation, and AI for Health are now widely recognized concepts in these discussions—a significant leap forward from our early engagements with EU policymakers.
However, important challenges remain. Despite progress in EU regulations and the growing openness of the MDR towards in silico methods, key questions still need answers:
- How should in silico data be reported for regulatory approval?
- How can computational models producing this evidence be validated?
- How do we equip regulators with in silico-savvy engineers capable of assessing this evidence?
We are pleased to see growing alignment on these issues and look forward to contributing to the next steps that will help make healthcare safer, faster, and more affordable — in Europe and beyond.
